TheraRadar
← Back
Data updated: Mar 29, 2026

I 3 PHARMS

ImmunologyInfectious DiseaseCardiovascular
Generics

I 3 PHARMS is a generic drug manufacturer focused on Immunology, Infectious Disease, Cardiovascular.

2023
Since
4
Drugs
-
Trials
30
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

TRANEXAMIC ACID 2026-01-26
MARAVIROC 2025-11-04
POSACONAZOLE 2025-10-29
Manufacturing (CMC)
TRANEXAMIC ACID 2025-08-20
Labeling
TRANEXAMIC ACID 2025-08-19
POSACONAZOLE 2025-07-10
Labeling
POSACONAZOLE 2025-07-03
Labeling
POSACONAZOLE 2025-07-02
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 33%
1 drugs
Infectious Disease 33%
1 drugs
Cardiovascular 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
Johnson & Johnson big-pharma
Immunology, Infectious Disease, Cardiovascular
COSETTE other
Cardiovascular, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Immunology
Pfizer big-pharma
Infectious Disease, Immunology